SG46649A1 - Compositions - Google Patents

Compositions

Info

Publication number
SG46649A1
SG46649A1 SG1996007136A SG1996007136A SG46649A1 SG 46649 A1 SG46649 A1 SG 46649A1 SG 1996007136 A SG1996007136 A SG 1996007136A SG 1996007136 A SG1996007136 A SG 1996007136A SG 46649 A1 SG46649 A1 SG 46649A1
Authority
SG
Singapore
Prior art keywords
pct
sec
date
date dec
pub
Prior art date
Application number
SG1996007136A
Other languages
English (en)
Inventor
Isabelle Richard
Isabelle Thielemans
Nadine Merlet
Original Assignee
Laboratoiresglaxo Wellcome Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoiresglaxo Wellcome Sa filed Critical Laboratoiresglaxo Wellcome Sa
Publication of SG46649A1 publication Critical patent/SG46649A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SG1996007136A 1992-05-07 1993-05-05 Compositions SG46649A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
SG46649A1 true SG46649A1 (en) 1998-02-20

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007136A SG46649A1 (en) 1992-05-07 1993-05-05 Compositions

Country Status (33)

Country Link
US (1) US5705506A (pt)
EP (1) EP0639072B1 (pt)
JP (1) JPH07506570A (pt)
KR (1) KR100253111B1 (pt)
AT (1) ATE163850T1 (pt)
AU (1) AU670083B2 (pt)
BE (1) BE1007024A5 (pt)
BG (1) BG62120B1 (pt)
BR (1) BR1100108A (pt)
CA (1) CA2135179C (pt)
CH (1) CH685920A5 (pt)
CY (1) CY2039B1 (pt)
CZ (1) CZ283512B6 (pt)
DE (1) DE69317418T2 (pt)
ES (1) ES2113533T3 (pt)
FR (1) FR2690847B1 (pt)
GB (2) GB9209882D0 (pt)
GR (1) GR3026584T3 (pt)
HK (1) HK95697A (pt)
HU (2) HU227338B1 (pt)
IE (1) IE75203B1 (pt)
IL (1) IL105468A (pt)
IT (1) IT1261471B (pt)
NO (1) NO306700B1 (pt)
NZ (1) NZ252132A (pt)
OA (1) OA10109A (pt)
RO (1) RO112993B1 (pt)
RU (1) RU2118527C1 (pt)
SG (1) SG46649A1 (pt)
TW (1) TW231970B (pt)
UA (1) UA37206C2 (pt)
WO (1) WO1993021916A1 (pt)
ZA (1) ZA933178B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
RU2214244C9 (ru) * 1998-03-26 2020-07-29 Астеллас Фарма Инк. Препараты с замедленным высвобождением
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2012048710A1 (en) 2010-10-15 2012-04-19 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
RU2670272C2 (ru) 2012-04-18 2018-10-22 Контера Фарма Апс Пероральная фармацевтическая композиция, подходящая для повышения эффективности лечения двигательных нарушений
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
US4997841A (en) * 1987-08-13 1991-03-05 Glaxo Group Limited Indole derivatives
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds

Also Published As

Publication number Publication date
GR3026584T3 (en) 1998-07-31
RO112993B1 (ro) 1998-03-30
BR1100108A (pt) 1999-12-07
ZA933178B (en) 1994-01-10
IL105468A (en) 1998-09-24
ITRM930286A1 (it) 1994-11-06
HU227338B1 (en) 2011-04-28
DE69317418D1 (de) 1998-04-16
GB2266665B (en) 1996-05-22
IT1261471B (it) 1996-05-23
IE930339A1 (en) 1993-11-17
TW231970B (pt) 1994-10-11
HK95697A (en) 1997-08-08
HU211638A9 (en) 1995-12-28
US5705506A (en) 1998-01-06
NZ252132A (en) 1996-09-25
BG62120B1 (bg) 1999-03-31
BG99167A (bg) 1995-06-30
NO944214L (no) 1994-11-07
EP0639072A1 (en) 1995-02-22
OA10109A (en) 1996-12-18
GB9209882D0 (en) 1992-06-24
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
ES2113533T3 (es) 1998-05-01
CH685920A5 (fr) 1995-11-15
DE69317418T2 (de) 1998-07-30
NO944214D0 (no) 1994-11-04
NO306700B1 (no) 1999-12-13
CZ283512B6 (cs) 1998-04-15
CY2039B1 (en) 1998-04-30
UA37206C2 (uk) 2001-05-15
JPH07506570A (ja) 1995-07-20
ATE163850T1 (de) 1998-03-15
RU2118527C1 (ru) 1998-09-10
ITRM930286A0 (it) 1993-05-06
FR2690847A1 (fr) 1993-11-12
GB2266665A (en) 1993-11-10
AU4064093A (en) 1993-11-29
AU670083B2 (en) 1996-07-04
WO1993021916A1 (en) 1993-11-11
BE1007024A5 (fr) 1995-02-21
IE75203B1 (en) 1997-08-27
CZ272394A3 (en) 1995-10-18
EP0639072B1 (en) 1998-03-11
FR2690847B1 (fr) 1995-06-09
CA2135179C (en) 2000-12-05
KR100253111B1 (en) 2000-07-01
CA2135179A1 (en) 1993-11-11
HUT71418A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
MX9702865A (es) Agentes estrogenicos.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
EP0903349A3 (en) CCR-3 receptor antagonists
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BG105534A (en) 5ht1 means and method for the treatment of migraine
SG46649A1 (en) Compositions
IL114598A0 (en) Triazole compounds their preparation and pharmaceutical compositions containing them
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
EP0485431A4 (en) Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
GR3036195T3 (en) Novel compounds
BG102229A (en) Endothelium receptor antagonists
FR2724933B1 (pt)
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
GR3026346T3 (en) Pharmaceutical compositions comprising contignasterol compounds.
IL150082A (en) Unsaturated 14,15 - cyclopropane